Esophageal Neoplasms D004938

Related MeSH Hierarchy (5)

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Digestive System Neoplasms » Gastrointestinal Neoplasms » Esophageal Neoplasms

Diseases [C] » Neoplasms [C04] » Neoplasms by Site » Head and Neck Neoplasms » Esophageal Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Digestive System Neoplasms » Gastrointestinal Neoplasms » Esophageal Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Esophageal Diseases » Esophageal Neoplasms

Diseases [C] » Digestive System Diseases [C06] » Gastrointestinal Diseases » Gastrointestinal Neoplasms » Esophageal Neoplasms

Description

Tumors or cancer of the ESOPHAGUS.   MeSH

Hierarchy View

Subtype Terms (1)

Esophageal Squamous Cell Carcinoma
72 drugs (26 approved, 46 experimental)


Approved Indicated Drugs (2)

Phase 2 Indicated Drugs (225)

Phase 1 Indicated Drugs (134)


Organization Involved with Phase 3 Indications (108)

Organization Involved with Phase 2 Indications (222)

Groupe Hospitalier Paris Saint Joseph

Grupo Espanol Multidisciplinario del Cancer Digestivo

Grupo Gallego de Investigaciones Oncologicas

Guangdong Pharmaceutical University

Guangzhou Anjie Biomedical Technology Co., Ltd.

Guangzhou Medical University

Hacettepe University

Hallym University

Halozyme Therapeutics

Hamamatsu University

Hangzhou Cancer Hospital

Helmholtz Centre for Infection Research

Hematology-Oncology Associates of Illinois

Hoag Memorial Hospital Presbyterian

Hokkaido University

Hoosier Cancer Research Network

Humboldt University

IKF Klinische Krebsforschung GmbH am Krankenhaus Nordwest

Immunomedics

Innate Pharma

Inner Mongolia Medical University

Innovent Biologics (Suzhou) Co. Ltd.

Institut de Cancerologie de l'Ouest Paul Papin

Institut Gustave Roussy

Ipsen

Jeil Pharmaceutical Co., Ltd.

Jinan University

Johannes Gutenburg University

Johns Hopkins University

J. W. Goethe University

Kantonsspital Aarau

Karolinska Institute

King Faisal Specialist Hospital

King Faisal University

Lee's Pharmaceutical

Lund University

Maastricht University

Mashhad University of Medical Sciences

McGill University

Mebiopharm Co., Ltd

Medac

Medical College of Wisconsin

Medical University Innsbruck

MedImmune

MedPacto, Inc.

Memorial Cancer Institute, Florida

Memorial Sloan-Kettering Cancer Center

Merrimack Pharmaceuticals

Millennium Pharmaceuticals

Nang Kuang Pharmaceutical Co., Ltd.

Nanjing University

National Cancer Center, Korea

National Comprehensive Cancer Network

Nationales Centrum fur Tumorerkrankungen

National Institutes of Health (NIH)

National Taiwan University

Hierarchy Tree View

UMLS Data


YOU AGREE THAT THE INFORMATION PROVIDED ON THIS WEBSITE IS PROVIDED “AS IS”, WITHOUT ANY WARRANTY OF ANY KIND, EXPRESSED OR IMPLIED, INCLUDING WITHOUT LIMITATION WARRANTIES OF MERCHANTABILITY OR FITNESS FOR ANY PARTICULAR PURPOSE, OR NON-INFRINGEMENT OF ANY THIRD-PARTY PATENT, COPYRIGHT, OR ANY OTHER THIRD-PARTY RIGHT. IN NO EVENT SHALL THE CREATORS OF THE WEBSITE OR WASHINGTON UNIVERSITY BE LIABLE FOR ANY DIRECT, INDIRECT, SPECIAL, OR CONSEQUENTIAL DAMAGES ARISING OUT OF OR IN ANY WAY CONNECTED WITH THE WEBSITE, THE USE OF THE WEBSITE, OR THIS AGREEMENT, WHETHER IN BREACH OF CONTRACT, TORT OR OTHERWISE, EVEN IF SUCH PARTY IS ADVISED OF THE POSSIBILITY OF SUCH DAMAGES.